Media Coverage

Advanced Search
  • 09302022
    Physician's Weekly

    Dr. Jeffrey Dlott shares lessons 1 year after the National Kidney Foundation removed race from the kidney function equation. Since the COVID-19 pandemic first began, gaps in care across the United States have magnified exponentially. Long-standing disparities affecting different racial and ethnic subpopulations reached the forefront of public consciousness, with COVID-19 demonstrating the critical role of social determinants of health on care and outcomes.

  • 09292022

    One day you’re in active treatment for breast cancer, and the next you’re not. You may have expected to feel “normal” at this point, but it’s not happening. Not physically and not emotionally. Because the initial focus is on treatment, the aftereffects can come as quite a shock. While everyone’s experiences are different, this article will cover some common challenges of life after breast cancer. Dr. Yuri Fesko is an oncologist and senior medical director of oncology and pharma services at Quest Diagnostics. He told Healthline that side effects can develop months or even years after treatment ends. “Each patient’s experience is unique, so even if two individuals share the same diagnosis and received the same treatment, how their bodies cope and the side effects they experience or are impacted by can be completely different.”

  • 09262022
    Cleveland Business Journal

    When Quest Diagnostics Inc. acquired Cleveland HeartLab in 2017, some people figured the small heart disease test developer's days in Cleveland were numbered. Instead, the large medical testing company, based in Secaucus, New Jersey, invested in the Cleveland Clinic spinoff, doubling its footprint to 22,000 square feet and increasing employee headcount to 240 at a facility in Cleveland's MidTown neighborhood.

  • 09142022

    Hound Labs announced an agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, establishing Quest as the exclusive provider of laboratory services for confirmatory testing of positive breath sample results generated by the HOUND® CANNABIS BREATHALYZER, used by employers on location as an objective measure to detect and deter cannabis use during the workday.

  • 09132022
    Medical Economics

    Data released by the U.S. Department of Health and Human Services shows massive boosts in the use of telehealth during the COVID-19 pandemic. Our digital health company, Pack Health, also saw a surge in the use of our telehealth options over the last two years, including one-to-one health coaching.

  • 09082022

    The US Department of Health and Human Services announced on Wednesday that it has authorized the Food and Drug Administration to issue emergency use authorizations for monkeypox tests. The agency has issued the first EUA for a monkeypox test to Quest Diagnostics, the FDA said in a separate announcement.

  • 08272022
    Healthcare Weekly

    Quest Diagnostics announced August 17th the launch of a new obstetrics laboratory test panel which will help physicians screen all eligible pregnant people easily and reliably for hepatitis C (HCV) along with tests typically ordered during early pregnancy.

  • 08242022
    Medical Laboratory Observer

    Prior to the COVID-19 pandemic, we at Quest Diagnostics had begun the process of moving lab operations in our Northeast region to a new, state-of-the-art facility in Clifton, New Jersey. In January 2021, we started processing samples (both COVID-19 related and others) in the new facility — one of the largest medical laboratories globally.

  • 08162022

    Responding is Barry Sample, senior science consultant, Quest Diagnostics, Seneca, SC.

    Delta-9 THC – the psychoactive compound that gives marijuana users a high – is a real risk to workplace safety and isn’t the benign, harmless substance it may be believed to be by many Americans.

  • 08162022
    Inside Precision Medicine

    The idea of patient-centric, personalized, and at-home medicine is no longer a theory, let alone a wild idea whipped up by the imagination of Hanna-Barbera cartoonists from 60 years ago. It’s precisely the type of healthcare that Jay G. Wohlgemuth, MD. senior vice president, R&D, medical and chief medical officer at Quest Diagnostics, thinks is just at our fingertips. In his eyes, a healthcare system with a seamless, highly engaging, and online medical experience around preventative and chronic care is not out of reach.